LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/Japan Based Olympus Buys France Based FH ORTHO
Company News

Japan Based Olympus Buys France Based FH ORTHO

November 27, 2020 1 min read Premium comments

Advertisement

Japan Based Olympus Buys France Based FH ORTHO
Olympus + FH ORTHO logos + Olympus Executive Officer and Chief Operating Officer Nacho Abia / Source: Olympus Corporation
Secondary#fhortho#nachoabia#olympuscorporation

The 101-year old Japanese firm, Olympus Corporation, has announced its acquisition of Heimsbrunn, France-based FH ORTHO SAS, a 55-year old supplier of orthopedic implants and instruments.

Olympus, which is probably best known for its high-end camera and optics business, also has one of the largest and most respected precision medical products businesses in the world. Its life sciences divisions  began as suppliers of microscopes and thermometers. Today, Olympus supplies an extraordinarily wide array of high end, precision scientific and medical products.  In orthopedics, the company has focused on tools, instruments and implants which facilitate minimally invasive surgery.

Olympus Executive Officer and Chief Operating Officer Nacho Abia spoke with OTW about its expansion. “We see strong potential in orthopedics where we have valuable know-how when it comes to bone substitutes or minimally invasive surgery products already. We want to make full use of these capabilities for the benefit of patients by expanding our portfolio and distribution.”

Abia continued, “Olympus is already active in orthopedics in Japan through its joint venture Olympus Terumo Biomaterials [OTB]. However, in order to scale this field for larger markets, we were looking for a strong partner with a compatible portfolio and strong opportunity for distribution and found this in FH ORTHO. OTB products such as bone substitutes and HTO [high tibial osteotomy] related devices and the ultrasound device for arthroscopic surgery Olympus has just developed complement each other very well and we can now scale distribution.”

Founded over 55 years ago, FH ORTHO creates and produces orthopedic devices. Its surgeon-developed solutions can be found in more than 37 countries and include products dedicated to joint reconstruction, biologics, foot and ankle, ligament repair, spine, and trauma surgery.

Abia told OTW, “FH ORTHO has a broad range of products and global distribution channels in the orthopedic field, and FH ORTHO also has a long history of business operation in the orthopedic industry while Olympus has a high market share in a certain area, high tibial osteotomy (HTO), in a limited market, Japan. We expect a huge synergistic effect from this acquisition, combining the product portfolios and the distribution channels.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy